Friday, 15 November 2019

BeiGene prices lymphoma drug at $12,935 for a 30-day supply

China-based drugmaker BeiGene Ltd on Friday priced its drug, Brukinsa, to treat a rare form of lymphoma at $12,935 for a 30-day supply.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)